+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • ID: 5562563
  • Report
  • March 2022
  • Region: Global
  • 140 Pages
  • IMARC Group
The global specialty generics market reached a value of US$ 60.8 Billion in 2021. Looking forward, the market is forecast to reach US$ 115.1 Billion by 2027, exhibiting at a CAGR of 11.11% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.



Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don’t require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc.

Key Market Segmentation:


The publisher provides an analysis of the key trends in each sub-segment of the global specialty generics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on route of administration, indication and distribution channel.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Italy
  • Germany
  • Spain
  • United Kingdom
  • France
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others

Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Competitive Landscape:


The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

The report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.

Key Questions Answered in This Report


1. What is the size of the global specialty generics market?
2. What are the key factors driving the global specialty generics market?
3. What has been the impact of COVID-19 on the global specialty generics market?
4. What is the breakup of the global specialty generics market based on the route of administration?
5. What is the breakup of the global specialty generics market based on the indication?
6. What is the breakup of the global specialty generics market based on the distribution channel?
7. What are the key regions in the global specialty generics market?
8. Who are the key players/companies in the global specialty generics market?
Frequently Asked Questions about the Global Specialty Generics Market

What is the estimated value of the Global Specialty Generics Market?

The Global Specialty Generics Market was estimated to be valued at $60.8 Billion in 2021.

What is the growth rate of the Global Specialty Generics Market?

The growth rate of the Global Specialty Generics Market is 11.2%, with an estimated value of $115.1 Billion by 2027.

What is the forecasted size of the Global Specialty Generics Market?

The Global Specialty Generics Market is estimated to be worth $115.1 Billion by 2027.

Who are the key companies in the Global Specialty Generics Market?

Key companies in the Global Specialty Generics Market include Teva Pharmaceuticals Industries, Akorn Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals and Endo International plc..

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary4 Global Specialty Generics Market: Introduction5 Why are Specialty Generics So Lucrative?
6 Global Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Route of Administration
6.5 Market Breakup by Indication
6.6 Market Breakup by Distribution Channel
6.7 Market Breakup by Region
6.8 Market Forecast
6.9 SWOT Analysis
6.9.1 Overview
6.9.2 Strengths
6.9.3 Weaknesses
6.9.4 Opportunities
6.9.5 Threats
6.10 Value Chain Analysis
6.11 Porters Five Forces Analysis
6.11.1 Overview
6.11.2 Bargaining Power of Buyers
6.11.3 Bargaining Power of Suppliers
6.11.4 Degree of Competition
6.11.5 Threat of New Entrants
6.11.6 Threat of Substitutes
6.12 Key Market Drivers and Success Factors
7 Market Breakup by Route of Administration
7.1 Injectable
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Indication
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Hospital Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Overview
10.1.2 Market Performance
10.1.3 Market Breakup by Country
10.1.3.1 United States
10.1.3.1.1 Market Trends
10.1.3.1.2 Market Forecast
10.1.3.2 Canada
10.1.3.2.1 Market Trends
10.1.3.2.2 Market Forecast
10.1.4 Market Forecast
10.2 Europe
10.2.1 Market Overview
10.2.2 Market Performance
10.2.3 Market Breakup by Country
10.2.3.1 Italy
10.2.3.1.1 Market Trends
10.2.3.1.2 Market Forecast
10.2.3.2 Germany
10.2.3.2.1 Market Trends
10.2.3.2.2 Market Forecast
10.2.3.3 France
10.2.3.3.1 Market Trends
10.2.3.3.2 Market Forecast
10.2.3.4 United Kingdom
10.2.3.4.1 Market Trends
10.2.3.4.2 Market Forecast
10.2.3.5 Spain
10.2.3.5.1 Market Trends
10.2.3.5.2 Market Forecast
10.2.4 Market Forecast
10.3 Asia Pacific
10.3.1 Market Overview
10.3.2 Market Performance
10.3.3 Market Breakup by Country
10.3.3.1 Japan
10.3.3.1.1 Market Trends
10.3.3.1.2 Market Forecast
10.3.3.2 China
10.3.3.2.1 Market Trends
10.3.3.2.2 Market Forecast
10.3.3.3 India
10.3.3.3.1 Market Trends
10.3.3.3.2 Market Forecast
10.3.3.4 South Korea
10.3.3.4.1 Market Trends
10.3.3.4.2 Market Forecast
10.3.4 Market Forecast
10.4 Latin America
10.4.1 Market Overview
10.4.2 Market Performance
10.4.3 Market Breakup by Country
10.4.3.1 Brazil
10.4.3.1.1 Market Trends
10.4.3.1.2 Market Forecast
10.4.3.2 Mexico
10.4.3.2.1 Market Trends
10.4.3.2.2 Market Forecast
10.4.4 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Overview
10.5.2 Market Performance
10.5.3 Market Forecast
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
11.3.1 Teva Pharmaceuticals Industries
11.3.2 Akorn, Inc.
11.3.3 Mylan N.V.
11.3.4 Mallinckrodt
11.3.5 Sandoz International GmbH
11.3.6 Pfizer, Inc.
11.3.7 Sun Pharmaceutical Industries Ltd.
11.3.8 Valeant Pharmaceuticals
11.3.9 Apotex Corp.
11.3.10 Endo International plc.
List of Figures
Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2016-2021
Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2021
Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2021
Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2021
Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2021
Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 7: Global: Specialty Generics Industry: SWOT Analysis
Figure 8: Global: Specialty Generics Industry: Value Chain Analysis
Figure 9: Global: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2016 & 2021
Figure 11: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 12: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2016 & 2021
Figure 13: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 14: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2016 & 2021
Figure 15: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 16: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2016 & 2021
Figure 17: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 18: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2016 & 2021
Figure 19: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 20: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2016 & 2021
Figure 21: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 22: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2016 & 2021
Figure 23: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 24: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2016 & 2021
Figure 25: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2022-2027
Figure 26: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2016 & 2021
Figure 27: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2022-2027
Figure 28: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2016 & 2021
Figure 29: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2022-2027
Figure 30: North America: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Specialty Generics Market: Breakup by Country (in %), 2021
Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Europe: Specialty Generics Market: Breakup by Country (in %), 2021
Figure 39: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Italy: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Germany: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: France: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Spain: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Asia Pacific: Specialty Generics Market: Breakup by Country (in %), 2021
Figure 52: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: China: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: India: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Latin America: Specialty Generics Market: Breakup by Country (in %), 2021
Figure 63: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
List of Tables
Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2022-2027
Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2022-2027
Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2022-2027
Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2022-2027
Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2021 and 2027
Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2021 and 2027
Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2021 and 2027
Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2021 and 2027
Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2021 and 2027
Table 11: Global: Specialty Generics Market Structure
Table 12: Global: Specialty Generics Market: Key Players

Companies Mentioned

  • Teva Pharmaceuticals Industries
  • Akorn Inc.
  • Mylan N.V.
  • Mallinckrodt
  • Sandoz International GmbH
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals
  • Apotex Corp.
  • Endo International plc.

Methodology

Loading
LOADING...